Tennyson completed his Master’s of Pharmacology degree at the University of Bath, which included a year-long placement with GlaxoSmithKline’s Large Molecule Discovery department. Here, he worked in the Antibody Protein Science and Antibody Pharmacology teams, gaining experience with biophysical and cell-based techniques. Presently, Tennyson is working towards his PhD with Brighton and Sussex Medical School, supervised by Chris Pepper, John Jones, and Emma Kennedy. The project, targeting NIK in Multiple Myeloma, is funded by Dr William Priddy, BSMS, and Sussex Cancer Fund.